Delisting risk
Synlogic (SYBX)
Former synthetic biology drug developer now seeking strategic alternatives.
$1.20
At close−0.02 (−1.64%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions2 holders · as of Mar 31, 2026 | 0.19% | 23.8K shares | |
| Insiders5 holders · as of Oct 31, 2025 | 11.48% | 1.41M shares | |
| Otherremainder | 88.33% | 10.82M shares |
12.25M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
2 holders · 23.8K shares · 0 new positions · 0 increased · 1 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| DRW Securities, LLC | 23.8K | 0.19% | −600 | May 13, 2026 |
| Hilltop National Bank | 20 | 0.00% | 0 | Apr 2, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Funicular Funds, LPincl. Ma-Weaver Jacob, Cable Car Capital, LP | 28.30% | 3.31M | 13D | Jul 29, 2026 ↗ |
| New Enterprise Associates 14, L.P.incl. NEA Partners 14, L.P., Nea 14 GP, Ltd +5 more | 25.00% | 2.92M | 13D | Jul 29, 2026 ↗ |
| Baselake Partners, LP | 9.70% | 1.14M | 13G | Jan 23, 2026 ↗ |
| Kryzanowski, John A. | 6.27% | 733.4K | 13G | Feb 25, 2025 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 27, 2026 | New Enterprise Associates 14, L.P.director, 10 percent owner: | Purchase | 2,640,845 | $0.7000 | 2,640,845 |
| Oct 29, 2025 | Mary Beth Dooleyofficer: See Remarks below | Sale | 157 | $1.81 | 12,744 |
CongressHouse and Senate disclosures
Not reported.
